SCHEMBL22816201

SCHEMBL22816201

CCOC(=O)c1c(CO[Si](C)(C)C(C)(C)C)nnn1Cc1ccc(OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.49
MAPT P10636 1/20 0.42
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41
TUBB2A Q13885 1/20 0.41
TUBB8 Q3ZCM7 1/20 0.41
TUBA3E Q6PEY2 1/20 0.41
TUBA1A Q71U36 1/20 0.41
TUBA1C Q9BQE3 1/20 0.41
TUBB6 Q9BUF5 1/20 0.41
TUBB2B Q9BVA1 1/20 0.41
TUBB1 Q9H4B7 1/20 0.41
AKR1C3 P42330 8/20 0.41
PDE8B O95263 1/20 0.40
ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3731878 0.84 UCHL1 (0.54) UCHL1MAPTTUBB4ATUBBTUBA3C
SCHEMBL1412433 0.84 UCHL1 (0.54) UCHL1MAPTTUBB4ATUBBTUBA3C
SCHEMBL4221650 0.79 UCHL1 (0.56) UCHL1MAPTTUBB4ATUBBTUBA3C
SCHEMBL22817056 0.78 CYP19A1 (0.44) UCHL1MAPTALDH1A1KDM4EUSP2
SCHEMBL5517220 0.78 UCHL1 (0.55) UCHL1MAPTALDH1A1KDM4EGAA
SCHEMBL29067895 0.78 AKR1C3 (0.57) UCHL1MAPTAKR1C3PDE8BPTGER4
SCHEMBL1412486 0.77 UCHL1 (0.52) UCHL1MAPTTUBB4ATUBBTUBA3C
SCHEMBL7830775 0.76 UCHL1 (0.53) UCHL1MAPTAKR1C3PDE8BALDH1A1
SCHEMBL3730522 0.76 UCHL1 (0.53) UCHL1MAPTTUBB4ATUBBTUBA3C
SCHEMBL31728363 0.75 UCHL1 (0.52) UCHL1MAPTTUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020257487-A1 GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2020-12-24 WO disclosed